OSH insider filings
Oak Street Health, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-05-04. Screen OSH transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for OSH between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Oak Street Health, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-05-04 | 4 | Newlight Partners LP — Director, 10% owner Newlight Harbour Point SPV LLC — 10% owner Newlight GP LLC — 10% owner Yadav Ravi — 10% owner WASSONG DAVID — 10% owner | Disposition to issuer (D): 32,550,265 @ $39 | EDGAR |
| 2023-05-02 | 4 | COOK TIMOTHY M — Chief Financial Officer | Disposition to issuer (D): 1,456,206 @ $39 · Disposition to issuer (D): 42,241 @ $39 · Disposition to issuer (D): 42,241 @ $39 · Disposition to issuer (D): 461,510 (derivative) @ $18 · Disposition to issuer (D): 10,212 (derivative) @ $18 · Disposition to issuer (D): 10,212 (derivative) @ $18 · +4 more | EDGAR |
| 2023-05-02 | 4 | Benjamin Regina M. — Director | Disposition to issuer (D): 23,881 @ $39 | EDGAR |
| 2023-05-02 | 4 | GUENTHNER ROBERT — Chief Legal Officer | Disposition to issuer (D): 489,270 @ $39 · Disposition to issuer (D): 220,406 (derivative) @ $18 · Disposition to issuer (D): 13,942 (derivative) @ $0 · Disposition to issuer (D): 134,271 (derivative) @ $23.25 · Grant/award (A): 49,000 (derivative) @ $0 · Disposition to issuer (D): 49,000 (derivative) @ $17.04 | EDGAR |
| 2023-05-02 | 4 | PYKOSZ MICHAEL T — Chief Executive Officer, Director | Disposition to issuer (D): 6,126,706 @ $39 · Disposition to issuer (D): 790,273 @ $39 · Disposition to issuer (D): 250,000 @ $39 · Disposition to issuer (D): 4,946,638 (derivative) @ $18 · Disposition to issuer (D): 168,052 (derivative) @ $18 · Disposition to issuer (D): 1,585,677 (derivative) @ $23.25 | EDGAR |
| 2023-05-02 | 4 | Kaushal Mohit — Director | Disposition to issuer (D): 215,224 @ $39 · Disposition to issuer (D): 3,501 (derivative) @ $18 | EDGAR |
| 2023-05-02 | 4 | MYERS GRIFFIN — Chief Medical Officer, Director | Gift (G): 8,500 @ $0 · Disposition to issuer (D): 8,511 @ $39 · Disposition to issuer (D): 4,845,659 @ $39 · Disposition to issuer (D): 1,677,412 (derivative) @ $18 · Disposition to issuer (D): 50,890 (derivative) @ $23.25 | EDGAR |
| 2023-05-02 | 4 | KECK KIM — Director | Disposition to issuer (D): 94,960 @ $39 · Disposition to issuer (D): 62,374 (derivative) @ $18 | EDGAR |
| 2023-05-02 | 4 | CLEM BRIAN — Chief Operating Officer | Disposition to issuer (D): 569,826 @ $39 · Disposition to issuer (D): 198,140 (derivative) @ $18 · Disposition to issuer (D): 27,884 (derivative) @ $0 · Disposition to issuer (D): 281,329 (derivative) @ $23.25 · Grant/award (A): 73,000 (derivative) @ $0 · Disposition to issuer (D): 73,000 (derivative) @ $17.04 | EDGAR |
| 2023-05-02 | 4 | PRICE GEOFFREY M — Chief Innovation Officer, Director | Disposition to issuer (D): 3,879,525 @ $39 · Disposition to issuer (D): 1,080,970 @ $39 · Disposition to issuer (D): 1,599,281 (derivative) @ $18 · Disposition to issuer (D): 281,329 (derivative) @ $23.25 · Grant/award (A): 24,000 (derivative) @ $0 · Disposition to issuer (D): 24,000 (derivative) @ $17.04 | EDGAR |
| 2023-05-02 | 4 | Klapstein Julie D — Director | Disposition to issuer (D): 31,684 @ $39 | EDGAR |
| 2023-05-02 | 4 | Dorsey Cheryl — Director | Disposition to issuer (D): 29,484 @ $39 | EDGAR |
| 2023-05-02 | 4 | Kusserow Paul B. K. — Director | Disposition to issuer (D): 480,013 @ $39 · Disposition to issuer (D): 23,342 (derivative) @ $18 | EDGAR |
| 2023-05-02 | 4 | GENERAL ATLANTIC, L.P. — Director, 10% owner GENERAL ATLANTIC GENPAR, L.P. — 10% owner General Atlantic Partners 93, L.P. — 10% owner General Atlantic Partners 100, L.P. — 10% owner GAP COINVESTMENTS III, LLC — 10% owner GAP COINVESTMENTS IV, LLC — 10% owner GAP Coinvestments V, LLC — 10% owner GAP Coinvestments CDA, L.P. — 10% owner General Atlantic (SPV) GP, LLC — 10% owner General Atlantic (OSH) Interholdco, L.P. — 10% owner | Other (J): 61,384,475 @ $39 | EDGAR |
| 2023-04-27 | 4 | Newlight Partners LP — Director, 10% owner Newlight Harbour Point SPV LLC — 10% owner Newlight GP LLC — 10% owner Yadav Ravi — 10% owner WASSONG DAVID — 10% owner | Gift (G): 80,000 @ $0 | EDGAR |
| 2023-04-25 | 4 | KECK KIM — Director | Grant/award (A): 5,140 @ $0 | EDGAR |
| 2023-04-25 | 4 | Kaushal Mohit — Director | Grant/award (A): 5,140 @ $0 | EDGAR |
| 2023-04-25 | 4 | Benjamin Regina M. — Director | Grant/award (A): 5,140 @ $0 | EDGAR |
| 2023-04-25 | 4 | Klapstein Julie D — Director | Grant/award (A): 5,140 @ $0 | EDGAR |
| 2023-04-25 | 4 | Dorsey Cheryl — Director | Grant/award (A): 5,140 @ $0 | EDGAR |
| 2023-04-25 | 4 | Kusserow Paul B. K. — Director | Grant/award (A): 5,140 @ $0 | EDGAR |
| 2023-04-24 | 4 | PRICE GEOFFREY M — Chief Innovation Officer, Director | Gift (G): 1,080,970 @ $0 · Other (J): 1,080,970 @ $0 | EDGAR |
| 2023-04-20 | 4 | PRICE GEOFFREY M — Chief Innovation Officer, Director | Option exercise (M): 50,000 @ $21 · Sale (S): 50,000 @ $38.88 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2023-04-12 | 4 | COOK TIMOTHY M — Chief Financial Officer | Sale (S): 5,978 @ $38.82 | EDGAR |
| 2023-04-12 | 4 | PRICE GEOFFREY M — Chief Innovation Officer, Director | Sale (S): 4,517 @ $38.82 | EDGAR |
| 2023-04-12 | 4 | GUENTHNER ROBERT — Chief Legal Officer | Sale (S): 3,169 @ $38.82 | EDGAR |
| 2023-04-06 | 4 | PRICE GEOFFREY M — Chief Innovation Officer, Director | Option exercise (M): 50,000 @ $21 · Sale (S): 50,000 @ $38.80 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2023-04-03 | 4 | PRICE GEOFFREY M — Chief Innovation Officer, Director | Option exercise (M): 200,000 @ $21 · Sale (S): 200,000 @ $38.69 · Option exercise (M): 250,000 @ $21 · Sale (S): 250,000 @ $38.69 · Option exercise (M): 250,000 (derivative) @ $0 · Option exercise (M): 200,000 (derivative) @ $0 | EDGAR |
| 2023-03-27 | 4 | PYKOSZ MICHAEL T — Chief Executive Officer, Director | Gift (G): 1,282,000 @ $0 | EDGAR |
| 2023-03-22 | 4 | PRICE GEOFFREY M — Chief Innovation Officer, Director | Grant/award (A): 5,611 @ $0 · Option exercise (M): 50,000 @ $21 · Sale (S): 50,000 @ $35.73 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2023-03-22 | 4 | GUENTHNER ROBERT — Chief Legal Officer | Grant/award (A): 47,699 @ $0 | EDGAR |
| 2023-03-22 | 4 | COOK TIMOTHY M — Chief Financial Officer | Grant/award (A): 92,592 @ $0 | EDGAR |
| 2023-03-22 | 4 | MYERS GRIFFIN — Chief Medical Officer, Director | Grant/award (A): 5,611 @ $0 | EDGAR |
| 2023-03-22 | 4 | CLEM BRIAN — Chief Operating Officer | Grant/award (A): 101,010 @ $0 | EDGAR |
| 2023-03-22 | 4 | PYKOSZ MICHAEL T — Chief Executive Officer, Director | Grant/award (A): 196,408 @ $0 | EDGAR |
| 2023-03-22 | 4/A | PRICE GEOFFREY M — Chief Innovation Officer, Director | Option exercise (M): 1,831 @ $21 | EDGAR |
| 2023-03-21 | 4 | PRICE GEOFFREY M — Chief Innovation Officer, Director | Option exercise (M): 37,913 @ $21 · Sale (S): 37,913 @ $35.63 · Option exercise (M): 37,913 (derivative) @ $21 | EDGAR |
| 2023-03-17 | 4 | PRICE GEOFFREY M — Chief Innovation Officer, Director | Option exercise (M): 1,831 @ $21 · Sale (S): 1,831 @ $35.60 · Option exercise (M): 79,858 @ $21 · Sale (S): 79,858 @ $35.62 · Option exercise (M): 1,831 (derivative) @ $21 · Option exercise (M): 79,858 (derivative) @ $21 | EDGAR |
| 2023-03-15 | 4 | PRICE GEOFFREY M — Chief Innovation Officer, Director | Grant/award (A): 11,296 @ $0 | EDGAR |
| 2023-03-15 | 4 | MYERS GRIFFIN — Chief Medical Officer, Director | Grant/award (A): 2,852 @ $0 | EDGAR |
| 2023-03-15 | 4 | COOK TIMOTHY M — Chief Financial Officer | Grant/award (A): 17,458 @ $0 | EDGAR |
| 2023-03-15 | 4 | GUENTHNER ROBERT — Chief Legal Officer | Grant/award (A): 11,981 @ $0 | EDGAR |
| 2023-03-15 | 4 | PYKOSZ MICHAEL T — Chief Executive Officer, Director | Grant/award (A): 25,605 @ $0 | EDGAR |
| 2023-03-13 | 4 | GUENTHNER ROBERT — Chief Legal Officer | Sale (S): 8,250 @ $35.43 | EDGAR |
| 2023-03-09 | 4 | PRICE GEOFFREY M — Chief Innovation Officer, Director | Option exercise (M): 50,000 @ $21 · Sale (S): 50,000 @ $35.54 · Option exercise (M): 50,000 (derivative) @ $21 | EDGAR |
| 2023-02-27 | 4 | PRICE GEOFFREY M — Chief Innovation Officer, Director | Sale (S): 7,728 @ $35.48 | EDGAR |
| 2023-02-27 | 4 | GUENTHNER ROBERT — Chief Legal Officer | Sale (S): 8,250 @ $35.46 · Sale (S): 2,518 @ $35.48 | EDGAR |
| 2023-02-27 | 4 | COOK TIMOTHY M — Chief Financial Officer | Sale (S): 5,107 @ $35.48 | EDGAR |
| 2023-02-23 | 4 | PRICE GEOFFREY M — Chief Innovation Officer, Director | Option exercise (M): 50,000 @ $21 · Sale (S): 50,000 @ $35.32 · Option exercise (M): 122,985 @ $21 · Sale (S): 122,985 @ $35.61 · Option exercise (M): 50,000 (derivative) @ $21 · Option exercise (M): 122,985 (derivative) @ $21 | EDGAR |
| 2023-02-13 | 4 | GUENTHNER ROBERT — Chief Legal Officer | Sale (S): 8,250 @ $35.26 | EDGAR |
Recent 8-K events — Oak Street Health, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-05-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-01 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2023-04-21 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-04-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-03-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-03-13 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-02-28 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2023-02-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-02-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-01-09 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=OSH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs